Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amarin Corporation plc (AMRN)

17.58   -0.35 (-1.95%) 02-24 16:00
Open: 17.35 Pre. Close: 17.93
High: 17.705 Low: 16.8
Volume: 6,771,384 Market Cap: 6310M
Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.722 - 17.809 17.809 - 17.893
Low: 16.553 - 16.658 16.658 - 16.762
Close: 17.377 - 17.551 17.551 - 17.722

Technical analysis

as of: 2020-02-24 4:41:03 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 23.25     One year: 25.49
Support: Support1: 16.80    Support2: 13.98
Resistance: Resistance1: 19.90    Resistance2: 21.82
Pivot: 18.07
Moving Average: MA(5): 17.93     MA(20): 18.40
MA(100): 19.09     MA(250): 18.57
MACD: MACD(12,26): -0.60     Signal(9): -0.62
Stochastic oscillator: %K(14,3): 33.07     %D(3): 32.22
RSI: RSI(14): 37.81
52-week: High: 26.12  Low: 13.76  Change(%): -12.1
Average Vol(K): 3-Month: 809892  10-Days: 505838

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AMRN has closed above bottom band by 17.8%. Bollinger Bands are 61.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 19 Feb 2020 17:36:26 +0000
Why Amarin Stock Is Getting No Love Early in 2020

Wed, 19 Feb 2020 11:40:11 +0000
Positive Catalysts Make Amarin Stock a Buy on Current Weakness

Mon, 17 Feb 2020 14:57:00 +0000
6 Healthcare Stocks That Could Make You Filthy Rich

Fri, 14 Feb 2020 16:41:45 +0000
Risks Remain, but Amarin Stock Is a Buy at Today’s Prices

Thu, 06 Feb 2020 16:42:00 +0000
4 Dates Biotech Investors Should Circle in February

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 358.91
Shares Float (M) 310.08
% Held by Insiders 1.04
% Held by Institutions 55.26
Shares Short (K) 44560
Shares Short P. Month (K)

Stock Financials

EPS -0.190
Book Value (p.s.) 1.610
PEG Ratio -7.16
Profit Margin -17.42
Operating Margin -16.92
Return on Assets (ttm) -7.1
Return on Equity (ttm) -23.3
Qtrly Rev. Growth 103.2
Gross Profit (p.s.) 0.487
Sales Per Share
EBITDA (p.s.) -0.169
Qtrly Earnings Growth
Operating Cash Flow (M) -32.73
Levered Free Cash Flow (M) -12.34

Stock Valuations

P/E -92.53
P/E Growth Ratio -0.02
P/BV 10.92
P/S 15.98
P/CF -192.78

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.